Quantcast

Latest Cancer treatments Stories

2014-04-07 08:29:57

PRINCETON, N.J., April 7, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Dental and Craniofacial Research (NIDCR) has awarded Soligenix a Small Business Innovation Research (SBIR) grant...

2014-04-04 23:36:36

Active research in breast cancer is producing novel targeted drugs at a rapid pace. Thousand Oaks, California (PRWEB) April 03, 2014 As the Cancer society continues research for breast cancer, several options have emerged. Of these options three drugs have been approved by the FDA for usage as treatment and no one is more excited than Dr. Mai Brooks. Perjeta (pertuzumab) In September 2013, the FDA approved Perjeta for use in combination with Herceptin (trastuzumab) and docetaxel for the...

2014-04-04 23:27:07

Immunotherapy is one of the most exciting new approaches to treating cancer. Dr. Carl June will discuss his findings May 14 as featured speaker at UC San Diego. (PRWEB) April 04, 2014 A world leader in immunotherapy, Carl June, will discuss the emergence of a new form of targeted immunotherapy to treat cancer, Wednesday, May 14, 5:30 pm to 7 pm., at UC San Diego. June, professor of immunotherapy at the University of Pennsylvania, will discuss his pioneering work and also the barriers and...

2014-03-31 10:00:45

Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging. Researchers measured the level of p16, a protein that causes cellular aging, in the blood of 33 women over the age of 50 who had undergone chemotherapy for curable breast...

2014-03-31 09:54:57

UT Southwestern Medical Center researchers are developing a new predictive tool that could help patients with breast cancer and certain lung cancers decide whether follow-up treatments are likely to help. Dr. Jerry Shay, Vice Chairman and Professor of Cell Biology at UT Southwestern, led a three-year study on the effects of irradiation in a lung cancer-susceptible mouse model. When his team looked at gene expression changes in the mice, then applied them to humans with early stage cancer,...

2014-03-31 08:29:19

SANTA MONICA, Calif., March 31, 2014 /PRNewswire/ -- Kite Pharma, Inc. (Kite), a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT(TM)) products for cancer, today announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development granted orphan drug designation for the Company's lead investigational therapy, an autologous engineered T cell product that targets CD19 expression on B cell malignancies, for...

2014-03-31 08:28:39

Patients in Ontario and Atlantic Canada face significant challenges accessing oral medications due to their age, cancer type and where they live TORONTO, March 31, 2014 /CNW/ - The CanCertainty Coalition - an unprecedented unification of more than 30 Canadian patient groups, physicians, and health charities today released a powerful video highlighting the significant challenges cancer patients in Ontario and Atlantic Canada face in accessing oral medications. The video's message...

2014-03-29 23:01:54

A new study finds that a drug that kills bladder cancer cells with light works even better when another compound is added. Raleigh, NC (PRWEB) March 29, 2014 The Chinese developers of a light-based treatment for bladder cancer say the treatment can be improved with the addition of a second drug. Click here to read the findings, which have just been posted on the Cancer Monthly website. Doctors in the Department of Urology at Fudan University in Shanghai have concluded that the...

2014-03-27 08:34:30

BETHESDA, Md., March 27, 2014 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for cancer, announced today that Linda Powers, CEO, will present at the 4(th) Annual "Cancer Immunotherapy: A Long-Awaited Reality" conference being held at the New York Academy of Medicine in New York City on Thursday, March 27 at 2:45 pm ET. During her presentation, Ms. Powers will provide an...

2014-03-26 23:26:31

A report to the nation’s bladder cancer specialists says more of them should be taking a multidisciplinary approach to treating their patients with bladder cancer. Raleigh, NC (PRWEB) March 26, 2014 Researchers say treating the invasive form of bladder cancer with both surgery and chemotherapy can improve survival, especially if chemotherapy is delivered prior to surgery. Click here to see details of the new report, which has just been posted by Cancer Monthly. In a report presented at...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related